Pathology and Molecular Medicine, McMaster University, Hamilton, ON Canada.
Gut Microbes. 2013 Mar-Apr;4(2):94-100. doi: 10.4161/gmic.23283. Epub 2012 Dec 18.
There has been continued and expanding recognition of probiotic approaches for treating gastrointestinal and systemic disease, as well as increased acceptance of probiotic therapies by both the public and the medical community. A parallel development has been the increasing recognition of the diverse roles that the normal gut microbiota plays in the normal biology of the host. This advance has in turn has been fed by implementation of novel investigative technologies and conceptual paradigms focused on understanding the fundamental role of the microbiota and indeed all commensal bacteria, on known and previously unsuspected aspects of host physiology in health and disease. This review discusses current advances in the study of the host-microbiota interaction, especially as it relates to potential mechanisms of probiotics. It is hoped these new approaches will allow more rational selection and validation of probiotic usage in a variety of clinical conditions.
人们对益生菌治疗胃肠道和全身性疾病的方法有了持续且不断扩大的认识,公众和医学界对益生菌疗法的接受度也在提高。与此同时,人们对正常肠道微生物群在宿主正常生物学中发挥的多种作用的认识也在不断提高。这一进展反过来又得益于新型研究技术的实施和概念范式的引入,这些技术和范式专注于理解微生物群,甚至所有共生菌在宿主生理的已知和以前未被怀疑的方面的基本作用,无论是在健康还是疾病中。本文讨论了宿主-微生物群相互作用研究的最新进展,特别是其与益生菌的潜在机制的关系。希望这些新方法能够更合理地选择和验证益生菌在各种临床情况下的应用。